Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | CTSK | P43235 | 4/20 | 0.49 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.49 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.49 |
| ▸ | CTSB | P07858 | 2/20 | 0.48 |
| ▸ | REN | P00797 | 1/20 | 0.47 |
| ▸ | MMP1 | P03956 | 2/20 | 0.47 |
| ▸ | CTSS | P25774 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27556474 | 0.91 | SLC15A1 (0.58) | HSD17B10CTSKSLC15A1CTSBCTSS | |
| SCHEMBL27556472 | 0.91 | SLC15A1 (0.58) | HSD17B10CTSKSLC15A1CTSBCTSS | |
| SCHEMBL8048833 | 0.87 | HSD17B10 (0.52) | HSD17B10CTSKSLC15A1CTSBCTSS | |
| SCHEMBL7355706 | 0.87 | HSD17B10 (0.52) | HSD17B10CTSKSLC15A1CTSBCTSS | |
| SCHEMBL9574213 | 0.85 | ABCB1 (0.57) | ABCB1SLC15A1CTSBALDH1A1 | |
| SCHEMBL8038393 | 0.85 | MAPT (0.48) | HSD17B10CTSKSLC15A1CTSBALDH1A1 | |
| SCHEMBL6447818 | 0.85 | MAPT (0.48) | HSD17B10CTSKSLC15A1CTSBALDH1A1 | |
| SCHEMBL8216230 | 0.83 | SLC15A1 (0.47) | HSD17B10CTSKSLC15A1CTSBCTSS | |
| SCHEMBL8216233 | 0.83 | SLC15A1 (0.47) | HSD17B10CTSKSLC15A1CTSBCTSS | |
| SCHEMBL19996989 | 0.82 | SLC15A1 (0.65) | HSD17B10CTSKSLC15A1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0558648-B1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GALARDY RICHARD E (US) | 2004-04-28 | — | — | EP | disclosed |
| EP-0663823-B1 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED INC (US) | 2000-11-22 | — | — | EP | disclosed |
| US-5892112-A | ACYLATION OF AMINO ACIDS WITH ANHYDRIDES OR CARBOXY GROUPS, AMIDATION WITH AMINE AND CONVERSION OF ACID OR ESTER TO HYDROXAMIC ACID AND HYDROLYSIS | GLYCOMED INCORPORATED (US) | 1999-04-06 | — | — | US | disclosed |
| US-5773438-A | SKIN DISORDERS, RESTENOSIS, RHEUMATIC ARTHRITIS, WOUND HEALING AGENTS, ANGIOGENESIS, SHOCK | GLYCOMED INCORPORATED (US) | 1998-06-30 | — | — | US | disclosed |
| EP-0558681-B1 | TREATMENT FOR TISSUE ULCERATION | UNIV FLORIDA (US) | 1998-04-08 | — | — | EP | disclosed |
| US-5696147-A | CONTROLLING GROWTH OF TUMORS AND NEOVASCULAR GLAUCOMAS | GLYCOMED, INC. (US) | 1997-12-09 | — | — | US | disclosed |
| EP-0558635-B1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED INC (US) | 1997-09-10 | — | — | EP | disclosed |
| EP-0692931-A4 | SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS AND USES THEREOF | GLYCOMED INC (US) | 1996-03-20 | — | — | EP | disclosed |
| EP-0690841-A4 | SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS AND USES THEREOF | GLYCOMED INC (US) | 1996-03-13 | — | — | EP | disclosed |
| EP-0692931-A1 | SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS AND USES THEREOF | GLYCOMED INCORPORATED (US) | 1996-01-24 | — | — | EP | disclosed |
| US-5270326-A | Administering inhibitor of mammalian matrix metalloprotease | UNIVERSITY OF FLORIDA (US) | 1993-12-14 | — | — | US | disclosed |
| US-5268384-A | Containing amide groups | GLYCOMED, INC., A CA CORP | 1993-12-07 | — | — | US | disclosed |
| EP-0558681-A4 | TREATMENT FOR TISSUE ULCERATION | — | 1993-11-18 | — | — | EP | disclosed |
| EP-0558681-A1 | TREATMENT FOR TISSUE ULCERATION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 1993-09-08 | — | — | EP | disclosed |
| US-5239078-A | Collagenase enzyme inhibitors | GLYCOMED INCORPORATED (US) | 1993-08-24 | — | — | US | disclosed |
| WO-1993013741-A2 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED, INC. (US) | 1993-07-22 | — | — | WO | disclosed |
| US-5189178-A | Preventing protein destruction | GALARDY RICHARD E (US) | 1993-02-23 | — | — | US | disclosed |
| US-5183900-A | Matrix metalloprotease inhibitors | GALARDY RICHARD E (US) | 1993-02-02 | — | — | US | disclosed |
| WO-1992009282-A1 | TREATMENT FOR TISSUE ULCERATION | THE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 1992-06-11 | — | — | WO | disclosed |
| US-5114953-A | Peptides | UNIVERSITY OF FLORIDA (US) | 1992-05-19 | — | — | US | disclosed |